Home
Dashboard
Curated content
Themes
Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council
Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations
Events
Investment heatmap
Matching tool
Companies
InvaGen Pharmaceuticals
Save
InvaGen Pharmaceuticals
Fast growing generic pharmaceutical company.
Launch date
2003
Employees
51-200 people
Market cap
-
Enterprise valuation
€455m
(Public information from Sep 2015)
Town of Smithtown New York (HQ)
http://invagen.com
https://www.linkedin.com/company/cipla-usa/
B2B
manufacturing
health
marketing
crm & sales
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
InvaGen Pharmaceuticals funding
InvaGen Pharmaceuticals investors
Edit
Date
Investors
Amount
Round
Sep 2015
Cipla
$500m
Valuation: $500m
Acquisition
Total Funding
-
Related Content
Recent News about InvaGen Pharmaceuticals
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access